Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
26.68 EUR | -1.13% | -6.92% | -20.62% |
04:32pm | Bayer: results for prostate cancer treatment | CF |
01:31pm | BAYER AG : JP Morgan reiterates its Neutral rating | ZD |
EPS & Dividend: Bayer AG
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Dividend per Share 2 | 2.8 | 2 | 2 | 2.4 | 0.11 | 0.1103 | 0.1103 | 1.118 |
Rate of return | 3.85% | 4.15% | 4.26% | 4.97% | 0.33% | 0.41% | 0.41% | 4.14% |
EPS 2 | 4.17 | -10.68 | 1.02 | 4.22 | -2.99 | 2.373 | 3.032 | 3.4 |
Distribution rate | 67.1% | -18.7% | 196% | 56.9% | -3.68% | 4.65% | 3.64% | 32.9% |
Reference price 2 | 72.81 | 48.16 | 47.00 | 48.32 | 33.63 | 26.98 | 26.98 | 26.98 |
Nbr of stocks (in thousands) | 982,424 | 982,424 | 982,424 | 982,424 | 982,424 | 982,424 | - | - |
Announcement Date | 2/27/20 | 2/25/21 | 3/1/22 | 2/28/23 | 3/5/24 | - | - | - |
Past dividends: Bayer AG
2024-04-28 | Annual 0.11 EUR |
2023-05-01 | Annual 2.4 EUR |
2022-05-01 | Annual 2 EUR |
2021-04-27 | Annual 2 EUR |
2020-04-28 | Annual 2.8 EUR |
2019-04-28 | Annual 2.8 EUR |
2018-05-27 | Annual 2.8 EUR |
2017-04-30 | Annual 2.7 EUR |
2016-05-01 | Annual 2.5 EUR |
2015-05-27 | 2.25 EUR |
Upcoming events: Bayer AG
Yield (Y) | Yield (Y+1) | P/E ratio | Price to Book | EV / Sales | ||
---|---|---|---|---|---|---|
+0.41% | +0.41% | 11.37x | 0.7660 | 1.28x | ||
+0.56% | +0.65% | 59.56x | 41.04 | 18.45x | ||
+1.24% | +1.64% | 40.44x | 28.34 | 14.09x | ||
+2.83% | +3.10% | 22.5x | 5.640 | 4.58x | ||
+3.21% | +3.32% | 37.8x | 41.05 | 7.16x | ||
+2.65% | +2.79% | 15.45x | 5.984 | 4.91x | ||
+3.71% | +3.81% | 15.86x | 5.878 | 3.76x | ||
+1.98% | +2.08% | 28.09x | 5.777 | 5.05x | ||
+3.26% | +3.39% | 21.48x | 5.253 | 4.95x | ||
+2.76% | +2.98% | 51.21x | 35.60 | 6.89x | ||
Average | +2.26% | +2.42% | 30.38x | 17.53 | 7.11x | |
Weighted average by Cap. | +2.03% | +2.21% | 36.90x | 23.42 | 10.03x |